Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Brii Biosciences Limited ( (HK:2137) ) just unveiled an announcement.
Brii Biosciences Limited has updated the terms of reference for its Nomination Committee, which is responsible for identifying and recommending candidates for the company’s board of directors. The committee’s structure and operational guidelines emphasize diversity and independence, aiming to enhance the board’s performance and governance, reflecting the company’s commitment to robust corporate governance practices.
The most recent analyst rating on (HK:2137) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Brii Biosciences Limited stock, see the HK:2137 Stock Forecast page.
More about Brii Biosciences Limited
Brii Biosciences Limited is a biotechnology company incorporated in the Cayman Islands, focusing on developing innovative therapies for infectious diseases and other significant health challenges.
YTD Price Performance: 85.71%
Average Trading Volume: 6,262,588
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.34B
See more insights into 2137 stock on TipRanks’ Stock Analysis page.